With respect to cell cycle control, loss-of-function mutations of cyclin dependent kinase inhibitor 2A/B (CDKN2A/B) can be found in half of all glioblastoma specimens, and cyclin-dependent kinase 4 (CDK4) is often highly amplified. The gene discussed is CDK4; the disease is glioblastoma.